Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
Abstract Ebola virus causes devastating hemorrhagic fever outbreaks for which no approved therapeutic exists. The viral nucleocapsid, which is minimally composed of the proteins NP, VP35, and VP24, represents an attractive target for drug development; however, the molecular determinants that govern...
Guardado en:
Autores principales: | Logan Banadyga, Thomas Hoenen, Xavier Ambroggio, Eric Dunham, Allison Groseth, Hideki Ebihara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2bfc0c3ea9f142f7be19ae38b181ed11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.
por: Allison Groseth, et al.
Publicado: (2012) -
A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus Infection
por: Travis K. Warren, et al.
Publicado: (2015) -
Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype
por: Santiago Vidal, et al.
Publicado: (2021) -
An upstream open reading frame modulates ebola virus polymerase translation and virus replication.
por: Reed S Shabman, et al.
Publicado: (2013) -
Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis
por: Wei Xu, et al.
Publicado: (2017)